Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus

Table 1 Summary of outcomes pre- and post-liver transplantation in human immunodeficiency virus-hepatitis B virus coinfected patients

Ref.	Patients, n	Study period in yr	Pre-LT				Post-LT
			Liver disease	CD4(+) T cell count as cells/μL	HIV-RNA as copies/mm3	HBV-DNA as IU/mL	Median follow-up in mo	Latest CD4(+) T cell count as cells/μL	Latest HIV-RNA as copies/mm3	Latest HBV-DNA as IU/mL	Rejections, n	Survival after LT in mo
Tateo et al[12]	13	1999-2007	HBV	173 (118-615)1	100% < 40	100% < 12	32 ± 5.22	281 (10-810)1	100% < 40	100% < 12	2	100% 1 yr, 100% 3 yr, 100% 5 yr
Schreibman et al[27]	6	1999-2006	5 HBV, 1 ALF	100% > 100	100% < 200	66.7% < 12	60 (2-64)1	83.3% > 100	100% < 100	83.3% ND	1	66.7% 1 yr, 66.7% 3 yr, 66.7% 5 yr
Norris et al[25]	5	1995-2003	4 HBV, 1 ALF	187 (124-293)1	20% < 50	100% < 12	15 (6-65)1	467 (241-754)1	100% < 50	100% < 12	1	100% 1 yr, 100% 3 yr
Coffin et al[15]	22	2001-2007	21 HBV, 1 ALF	317 (38–1070)1	100% < 40	45.4% ND	42 (0.6-84)1	289 (48–744)1	NA	68% ND	5	85% 1 yr, 85% 3 yr
Vernadakis et al[1]	2	1996-2009	1 HBV, 1 ALF	219, 403	50% < 50	NA	3, 34	NA	NA	NA	0	3, 34
Neff et al[22]	4	1997-2001	2 HBV, 2 ALF	75% > 100	50% < 50	ND	21 (5-36)1	100% > 100	100% < 50	ND	3	100% 1 yr, 100% 3 yr
Anadol et al[23]	10	1997-2011	HBV	100% > 100	80% < 50	ND	NA	NA	ND	ND	1	80% 1 yr, 80% 3 yr, 80% 5 yr
Radecke et al[24]	1	1998-2001	HBV	196	380	NA	3	> 100	NA	NA	1	3
Schliefer et al[26]	1	1997-1999	ALF	477	< 80	NA	27	> 100	< 80	NA	0	27 (Alive)
Roland et al[21]	1	NA	HBV	439	ND	ND	20	305 to 700	ND	ND	0	20 (Alive)
Terrault et al[1]	4	2000-2002	HBV	175 (104-439)	100% < 75	ND	18, 25, 42, 48	315 (125-505)	ND	ND	0	100% 1 yr, 100% 3 yr

¹Median (range);

²mean ± SD.

ALF: Acute liver failure; HBV: Hepatitis B virus; HIV: Human immunodeficiency virus; NA: Not available; ND: Not detectable; LT: Liver transplantation.